Skip to main content
. 2012 Jun 27;14(4):677–687. doi: 10.1208/s12248-012-9383-0

Fig. 2.

Fig. 2

Pharmacokinetic comparison of a nanosuspension and a lipid-based vehicle of Merck compound A, a BCS II compound, in rats. The nanosuspension provided significant better oral bioavailability compared to the lipid vehicle. Prolong absorption was observed from the nanosuspension formulation. Modified from (4)